Allelic deletions of the VHL gene detected in multiple microscopic clear cell renal lesions in von Hippel-Lindau disease patients.
about
Polycystin-1 regulates the stability and ubiquitination of transcription factor Jade-1Regulation of hypoxia-inducible mRNAs by the von Hippel-Lindau tumor suppressor protein requires binding to complexes containing elongins B/C and Cul2Transcription-dependent nuclear-cytoplasmic trafficking is required for the function of the von Hippel-Lindau tumor suppressor proteinJade-1, a candidate renal tumor suppressor that promotes apoptosisThe von Hippel-Lindau tumor-suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteinsInhibition of HIF2alpha is sufficient to suppress pVHL-defective tumor growthPreviously unidentified changes in renal cell carcinoma gene expression identified by parametric analysis of microarray dataBreaking through a plateau in renal cell carcinoma therapeutics: development and incorporation of biomarkersThe von Hippel-Lindau tumor suppressor protein controls ciliogenesis by orienting microtubule growth.A CULLINary ride across the secretory pathway: more than just secretion.Involvement of members of the cadherin superfamily in cancerMechanism of von Hippel-Lindau protein-mediated suppression of nuclear factor kappa B activity.Ocular manifestations of von Hippel-Lindau disease: clinical and genetic investigations.pVHL19 is a biologically active product of the von Hippel-Lindau gene arising from internal translation initiationDifferential genetic expression in large versus small clear cell renal cell carcinoma: results from microarray analysisUbiquitin pathway in VHL cancer syndrome.Two sides to every story: the HIF-dependent and HIF-independent functions of pVHL.Multiple neuroendocrine tumors of the pancreas in von Hippel-Lindau disease patients: histopathological and molecular genetic analysisHereditary and sporadic papillary renal carcinomas with c-met mutations share a distinct morphological phenotype.Histopathology and molecular genetics of multiple cysts and microcystic (serous) adenomas of the pancreas in von Hippel-Lindau patients.The molecular basis of von Hippel-Lindau diseaseProteostasis modulators prolong missense VHL protein activity and halt tumor progressionProgression of epididymal maldevelopment into hamartoma-like neoplasia in VHL disease.Combined mutation of Vhl and Trp53 causes renal cysts and tumours in miceLoss of vhl in the zebrafish pronephros recapitulates early stages of human clear cell renal cell carcinoma.Elongin BC complex prevents degradation of von Hippel-Lindau tumor suppressor gene products.Hereditary kidney cancer syndromes.Hypoxia-inducible factor-1α causes renal cyst expansion through calcium-activated chloride secretion.The hallmarks of cancer: relevance to the pathogenesis of polycystic kidney disease.PI3K/AKT/mTOR pathway plays a major pathogenetic role in glycogen accumulation and tumor development in renal distal tubules of rats and menSingle-cell genetic analysis validates cytopathological identification of circulating cancer cells in patients with clear cell renal cell carcinoma.
P2860
Q24299323-BE17C2BD-A81E-4AD7-900A-C462360BEE5EQ24523680-2F1A6015-4614-4FAD-8FC3-EFAD2B2223FBQ24530637-54EB04CD-4B37-42E2-BF25-EC74A638A7C4Q24534338-98A89BF4-A9B4-4990-94EE-6398C9FEEDD3Q24564802-E4784C30-9AF3-4013-B365-2D5FDDE4E481Q24800550-11626BE6-0D63-42A0-8C6B-345CADAF38C0Q24805313-1D6F78A5-0D95-43BD-B67D-844ADA057FACQ30472042-6402DDF2-3F6E-4FF8-A3FD-7528D530DF6AQ30480543-E1295999-27E5-4AC3-A5DD-3C26DA548889Q33819289-C0BCF107-0024-4C29-9E4A-B69F3429C369Q33899441-578067E2-407C-4D36-91B4-1E03716CD6B2Q33925065-B3663D34-3034-4E7E-8674-E25D5366BD58Q34565454-294E3D06-4433-4720-86C0-C8FB4B89E59AQ34753344-C614AED3-B4E1-488C-A67A-D4FC8AC354EEQ35001559-7F1DB016-B14C-497A-A304-49A16BF73CC9Q35082720-E2777341-4010-4515-B6D6-3F1EF61C43E9Q35589987-A6044CBF-6265-4E75-8179-BB61611C7587Q35753186-0DCD6BC6-E6D2-408A-9698-CB0C929AAAE7Q35787720-2F96A686-EE48-4051-AFC3-F472AA920D8FQ35829531-0A59E35D-BAE9-4E50-8973-8E39D0748B1CQ36437759-0DC661C3-D5E7-4F04-8F96-4792CE637FCDQ36585720-979E2F16-D66D-4179-8D10-481BE8A8595BQ36897801-60A125FB-D4F6-46E8-BFD3-7AC503C1B387Q37188593-C76CE38B-573C-4B6C-A782-7474283B3A28Q37224635-7F3D7F4E-E19D-4154-A827-7579143988CCQ37230912-D04F350A-EA53-45AC-88CA-4F1C863DB2ECQ37412363-E1770873-DB18-4A4B-A05F-0AF01E046024Q37604709-AD19F632-A722-4137-B8B8-8B498275B55CQ38419495-26C620AF-0303-4EAC-8B71-3AA3EAC6C503Q38878276-6E3D3674-E787-4CBD-BACF-F71003F92002Q55023971-445E3A92-9252-4023-9900-468A9A59E438
P2860
Allelic deletions of the VHL gene detected in multiple microscopic clear cell renal lesions in von Hippel-Lindau disease patients.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Allelic deletions of the VHL g ...... ippel-Lindau disease patients.
@ast
Allelic deletions of the VHL g ...... ippel-Lindau disease patients.
@en
type
label
Allelic deletions of the VHL g ...... ippel-Lindau disease patients.
@ast
Allelic deletions of the VHL g ...... ippel-Lindau disease patients.
@en
prefLabel
Allelic deletions of the VHL g ...... ippel-Lindau disease patients.
@ast
Allelic deletions of the VHL g ...... ippel-Lindau disease patients.
@en
P2093
P2860
P1476
Allelic deletions of the VHL g ...... ippel-Lindau disease patients.
@en
P2093
I A Lubensky
J R Gnarra
M M Walther
P Bertheau
W M Linehan
P2860
P304
P407
P577
1996-12-01T00:00:00Z